ImmunoPrecise Antibodies Ltd (NAS:IPA)
$ 0.77 -0.0233 (-2.94%) Market Cap: 21.02 Mil Enterprise Value: 29.23 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 53/100

Q2 2022 Immunoprecise Antibodies Ltd Earnings Call Transcript

Dec 13, 2021 / 09:30PM GMT
Release Date Price: $5.06 (-9.96%)
Operator

Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to ImmunoPrecise Antibodies fiscal year 2022 second-quarter earnings results and business highlights call. (Operator Instructions). Following the presentation, we will answer pre-submitted questions. (Operator Instructions). I would like to remind everyone that this conference call is being recorded today, December 13th, at 4:30 Eastern Time. I will now turn the call over to Chris Chu. Mr. Chu, please go ahead.

Chris Chu
LifeSci Advisors - Analyst

Thank you, and welcome. Dr. Jennifer Bath, President and Chief Executive Officer of ImmunoPrecise; and Ms. Lisa Helbling, Chief Financial Officer, will be the speakers on today's call. A Q&A period answering pre-submitted questions will follow their summary of the quarter followed by closing remarks. Before Dr. Bath begins, I've been asked by ImmunoPrecise to read the following Safe Harbor regarding forward-looking statements.

I would like to remind everyone that ImmunoPrecise's remarks today contain forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot